China Pledges To Accelerate Drug Reimbursement Process
This article was originally published in PharmAsia News
Executive Summary
China has agreed to update its national and regional drug reimbursement lists every two years, which should expand market access for new drugs developed by multinational companies
You may also be interested in...
U.S. Trade Rep’s IP Report: China Always Improving, Never Enough
Chinese officials’ seem able control piracy when they want to, as they did during the Beijing Olympics, but may be loosening up enforcement to protect jobs during the economic crisis, U.S. official says.
U.S. Trade Rep’s IP Report: China Always Improving, Never Enough
Chinese officials’ seem able control piracy when they want to, as they did during the Beijing Olympics, but may be loosening up enforcement to protect jobs during the economic crisis, U.S. official says.
Chinese Agencies’ Agreement Could Halve Approval Time For U.S. Devices
Chinese approval time for imported medical devices could be cut in half under an agreement to reduce redundancies between the country's Administration of Quality Supervision, Inspection and Quarantine and its State FDA